A1 Refereed original research article in a scientific journal

Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience




AuthorsPeltonen Sirkku, Jannic Arnaud, Wolkenstein Pierre

PublisherElsevier Masson s.r.l.

Publication year2022

JournalEuropean Journal of Medical Genetics

Journal name in sourceEuropean Journal of Medical Genetics

Article number104386

Volume65

Issue1

eISSN1878-0849

DOIhttps://doi.org/10.1016/j.ejmg.2021.104386

Web address https://www.sciencedirect.com/science/article/pii/S1769721221002524

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/174613303


Abstract

Cutaneous neurofibromas (cNF) are one of the hallmarks of neurofibromatosis 1 (NF1). The number of cNFs varies between individuals from a few to hundreds or even thousands and increases throughout adult life. cNFs cause a significant disease burden to adult patients and constitute an unmet need for therapy, since they may cause itch and pain and, being conspicuous and unsightly, stigmatize the patient. There is a lack of reports on how the outcome of various treatment options are perceived by the patients. Here we describe a technique for cNF removal using CO2 laser, and report how patients experience the procedure. Questionnaires were sent to patients who had had CO2 laser surgery in the French Referral Center for Neurofibromatoses, and in the Turku University Hospital, Finland, to retrospectively evaluate the patients’ global satisfaction of the procedure, treatment indications, and reasons for withdrawal from treatment, if this was the case. The number of returned questionnaires was 233/473 in France and 23/27 in Finland. The results showed that the most important indications for cNF removal were esthetic, and pain and itch caused by the tumors. In general, the procedure was well tolerated, and the degree of satisfaction was 8–10 on a scale from 0 to 10. For those 30% who discontinued the tumor removal program, the main reasons were organizational constraints, a non-satisfactory esthetic result, too many cNFs to treat, or problems with healing. Thus, the CO2 laser method is well tolerated but does not fully answer to the needs of the patients. Since medical treatment is not yet available, we encourage the use of laser removal of cNFs as a feasible method to decrease the tumor burden of the patients.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:46